Thrivent Financial for Lutherans Buys 25,807 Shares of Colgate-Palmolive Company $CL

Thrivent Financial for Lutherans boosted its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 19.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 157,983 shares of the company’s stock after purchasing an additional 25,807 shares during the period. Thrivent Financial for Lutherans’ holdings in Colgate-Palmolive were worth $14,361,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in CL. MASTERINVEST Kapitalanlage GmbH purchased a new position in shares of Colgate-Palmolive in the 2nd quarter worth $2,552,000. Silverlake Wealth Management LLC increased its position in Colgate-Palmolive by 9.6% during the second quarter. Silverlake Wealth Management LLC now owns 3,472 shares of the company’s stock valued at $316,000 after acquiring an additional 304 shares during the last quarter. Cim Investment Management Inc. lifted its holdings in Colgate-Palmolive by 99.6% in the second quarter. Cim Investment Management Inc. now owns 15,927 shares of the company’s stock valued at $1,448,000 after acquiring an additional 7,948 shares during the period. Saratoga Research & Investment Management boosted its position in Colgate-Palmolive by 1.1% in the second quarter. Saratoga Research & Investment Management now owns 195,696 shares of the company’s stock worth $17,789,000 after purchasing an additional 2,140 shares during the last quarter. Finally, Marex Group plc bought a new stake in shares of Colgate-Palmolive during the 2nd quarter valued at about $334,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Trading Down 0.6%

Shares of Colgate-Palmolive stock opened at $78.97 on Wednesday. Colgate-Palmolive Company has a fifty-two week low of $74.54 and a fifty-two week high of $100.18. The company has a debt-to-equity ratio of 5.90, a quick ratio of 0.60 and a current ratio of 0.93. The company has a market capitalization of $63.65 billion, a P/E ratio of 22.12, a P/E/G ratio of 5.66 and a beta of 0.30. The company has a fifty day moving average of $78.28 and a 200 day moving average of $83.28.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, October 31st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.89 by $0.02. The business had revenue of $5.13 billion for the quarter, compared to the consensus estimate of $5.17 billion. Colgate-Palmolive had a return on equity of 333.39% and a net margin of 14.47%.The business’s revenue was up 1.9% on a year-over-year basis. During the same period in the previous year, the business earned $0.91 earnings per share. On average, sell-side analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st will be paid a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 2.6%. The ex-dividend date is Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio is presently 58.26%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on CL shares. JPMorgan Chase & Co. dropped their price objective on shares of Colgate-Palmolive from $88.00 to $87.00 and set an “overweight” rating on the stock in a report on Monday, November 3rd. Barclays dropped their price target on shares of Colgate-Palmolive from $82.00 to $80.00 and set an “equal weight” rating on the stock in a research note on Tuesday, November 4th. The Goldman Sachs Group reduced their price objective on Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating for the company in a research note on Thursday, October 2nd. Deutsche Bank Aktiengesellschaft set a $86.00 target price on Colgate-Palmolive in a research report on Friday, October 10th. Finally, Bank of America reduced their price target on Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating for the company in a research report on Wednesday, October 8th. Ten analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Colgate-Palmolive has a consensus rating of “Moderate Buy” and an average target price of $88.75.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.